Literature DB >> 30054929

Clinically diagnosed urticaria and risk of systemic lupus erythematosus in children: A nationwide population-based case-control study.

Chien-Hung Lin1,2, Peir-Haur Hung3,4, Hsiao-Yun Hu5,6, Chi-Jung Chung7,8, Tsung-Hsien Chen4, Kuan-Yu Hung9.   

Abstract

BACKGROUND: Urticaria is one of the most common diseases seen in clinical practice, whereas several reports have proposed that urticaria may have a link with autoimmune disorders. Few studies have examined the clinical association between urticaria with systemic lupus erythematosus (SLE). By conducting a nationwide population-based case-control study in Taiwan, we evaluated the risk of SLE in children with a prior clinical diagnosis of urticaria.
METHODS: Using 2000-2011 claims data from the Taiwanese National Health Insurance Research Database, we identified 2105 SLE children during 2004-2011 as the study group, along with randomly selected 8420 non-SLE patients matched (1:4) for age, sex, and first diagnosis date as the control group. The correlation between urticaria and SLE risk was estimated using conditional logistic regression analysis.
RESULTS: The prevalence rates of clinically diagnosed acute and chronic urticaria in SLE patients were 22.09% and 18.24%, respectively. A significant association was found between clinically diagnosed urticaria and childhood SLE, with a stronger risk associated with more episodes of urticaria (≥3 visits, OR: 2.33, 95% CI 1.91-2.84). The risk was higher with chronic urticaria (OR: 2.21, 95% CI 1.85-2.64) than with acute urticaria (OR: 1.54, 95% CI 1.34-1.76). Subgroup analysis stratified by sex or age indicated that the risk associated with SLE was significantly greater among female children and adolescents with urticaria.
CONCLUSIONS: Our results suggest that children with urticaria have a significantly higher risk of SLE, with the risk increasing further among those with more episodes of urticaria or chronic urticaria.
© 2018 The Authors. Pediatric Allergy and Immunology Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  children; claims data; systemic lupus erythematosus; urticaria

Mesh:

Year:  2018        PMID: 30054929     DOI: 10.1111/pai.12962

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  2 in total

Review 1.  Pharmacologic Management of Chronic Urticaria in Pediatric Patients: The Gap Between Guidelines and Practice.

Authors:  Paul V Williams
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

2.  Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  Nipith Charoenngam; Ben Ponvilawan; Wasit Wongtrakul; Patompong Ungprasert
Journal:  Clin Rheumatol       Date:  2020-07-07       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.